Related Experiment Video
Updated: May 29, 2026
![Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F67458.jpg&w=3840&q=50)
Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level
Published on: January 24, 2025
Cerebral metabolic trajectories alterations in multiple system atrophy: A longitudinal FDG-PET study
Yixin Zhao1, Huamei Lin2, Xinyi Li1
1Department of Neurology, National Research Center for Aging and Medicine, National Center for Neurological Disorders, and State Key Laboratory of Brain Function and Disorders, Huashan Hospital, Fudan University, Shanghai, China.
Longitudinal 18F-FDG-PET reveals distinct metabolic decline in Multiple System Atrophy (MSA) subtypes. Parkinsonian MSA (MSA-P) shows putaminal decline, while cerebellar MSA (MSA-C) exhibits cerebellar metabolism loss, both linked to clinical progression.
Area of Science:
- Neuroscience
- Nuclear Medicine
- Metabolic Imaging
Background:
- Multiple System Atrophy (MSA) is a progressive neurodegenerative disorder with distinct parkinsonian (MSA-P) and cerebellar (MSA-C) subtypes.
- Understanding the longitudinal metabolic changes in these subtypes is crucial for early diagnosis and tracking disease progression.
Purpose of the Study:
- To characterize longitudinal changes in glucose metabolism and network connectivity in MSA subtypes using 18F-FDG-PET.
- To correlate metabolic decline with clinical progression measured by the Unified Multiple System Atrophy Rating Scale (UMSARS).
Main Methods:
- Retrospective analysis of 29 MSA patients (17 MSA-P, 12 MSA-C) and 28 healthy controls using 18F-FDG-PET.
- Assessment of regional glucose uptake (Standardized Uptake Value Ratios) and inter-regional connectivity via correlation analysis.
- Modeling metabolic decline using nonlinear mixed-effects models and correlating with UMSARS scores.
Main Results:
- MSA-P showed progressive hypometabolism in the putamen, cerebellum, and frontal cortex.
- MSA-C exhibited declines primarily in the cerebellum and frontal regions.
- Longitudinal modeling revealed faster putaminal decline in MSA-P and cerebellar decline in both subtypes, correlating with UMSARS progression. Significant connectivity disruptions were observed.
Conclusions:
- Longitudinal FDG-PET imaging demonstrates distinct metabolic decline patterns in MSA subtypes: putamen in MSA-P and cerebellum in MSA-C.
- These patterns are linked to clinical severity and progression.
- FDG-PET can aid in biological staging, disease monitoring, and evaluating treatment efficacy in MSA clinical trials.
![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)